JOURNEY MEDICAL CORP (DERM)

US48115J1097 - Common Stock

3.4  -0.1 (-2.86%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
63.13M
41.77%		73.67M
16.70%		79.181M
7.48%		59.173M
-25.27%
EBITDA
YoY % growth
-32.41M
-445.89%		-23.24M
28.29%		4.837M
120.81%		4.021M
-16.87%		N/A
EBIT
YoY % growth
-34.88M
-544.33%		-27.52M
21.10%		1.07M
103.89%		-14.989M
-1,500.83%
Operating Margin
-55.25%-37.36%1.35%-25.33%
EPS
YoY % growth
N/A-1.68-0.18
89.29%		-0.75
-319.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.24
57.95%
Revenue
Q2Q % growth		14.38M
17.77%
EBITDA
Q2Q % growth		139.74K
EBIT
Q2Q % growth		-4.491M
53.02%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.12
80.00%		-0.08-0.04-53.45%
Q3 2023
Q2Q % growth		 0.80
240.35%		-0.160.96606.01%
Q2 2023
Q2Q % growth		 -0.29
32.56%		-0.340.0515.13%
Q1 2023
Q2Q % growth		 -0.57
-612.50%		-0.46-0.11-25.11%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 15.257M
-4.46%		15.362M-105K-0.68%
Q3 2023
Q2Q % growth		 34.54M
114.27%		17.216M17.324M100.63%
Q2 2023
Q2Q % growth		 17.17M
-6.12%		15.104M2.066M13.68%
Q1 2023
Q2Q % growth		 12.21M
-47.60%		16.501M-4.291M-26.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-53.26% -23.68% -136.17% -111.43%
Revenue-3.7% -5.03% -8.37% -10.7%